Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1578-1588

  Ji, Fang ^a,b   Wang, You ^a,b,c   Qiu, Lihua ^a,b   Li, Shu ^a,b   Zhu, Jing ^a,b   Liang, Zhou ^a,b   Wan, Yinsheng ^d   Di, Wen ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Gynecologic Oncology   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d PROVIDENCE COLLEGE   (United States)

Author keywords

Hypoxia; Hypoxia inducible factor; Lysyl oxidase; Metastasis; Ovarian cancer; Reoxygenation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN LYSINE 6 OXIDASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTEIN-LYSINE 6-OXIDASE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84875983509     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1878     Document Type: Article

References (28)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007. (Pubitemid 46148091)
3. Rustin G, van der Burg M, Griffin C, Qian W and Swart AM: Early versus delayed treatment of relapsed ovarian cancer. Lancet 377: 380-381, 2011.
4. Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 291: 59-66, 2010.
5. Ricciardelli C and Oehler MK: Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas 62: 270-275, 2009.
6. Choi JY, Jang YS, Min SY and Song JY: Overexpression of MMP-9 and HIF-1α in breast cancer cells under hypoxic conditions. J Breast Cancer 14: 88-95, 2011.
7. Dayan F, Mazure NM, Brahimi-Horn MC and Pouyssegur J: A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenviron 1: 53-68, 2008.
8. Allen M and Louise Jones J: Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223: 162-176, 2011.
9. Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634, 2010.
10. Chen CL, Chu JS, Su WC, Huang SC and Lee WY: Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch 457: 53-61, 2010.
11. Lucero HA and Kagan HM: Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci 63: 2304-2316, 2006. (Pubitemid 44653041)
12. Payne SL, Hendrix MJ and Kirschmann DA: Paradoxical roles for lysyl oxidases in cancer - a prospect. J Cell Biochem 101: 1338-1354, 2007. (Pubitemid 47242767)
13. Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ and Kirschmann DA: Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. J Cell Biochem 103: 1369-1378, 2008. (Pubitemid 351490707)
14. Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A and Kandpal RP: Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25: 2328-2338, 2006.
15. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226, 2006.
16. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ and Kirschmann DA: Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65: 11429-11436, 2005. (Pubitemid 41821700)
17. Polgar N, Fogelgren B, Shipley JM and Csiszar K: Lysyl oxidase interacts with hormone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration. J Biol Chem 282: 3262-3272, 2007. (Pubitemid 47084331)
18. Fogelgren B, Polgar N, Szauter KM, Ujfaludi Z, Laczko R, Fong KS and Csiszar K: Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem 280: 24690-24697, 2005. (Pubitemid 40934558)
19. Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, Kanitakis J, Perrier E, Damour O and Sommer P: The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin Cancer Res 12: 1463-1469, 2006.
20. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
22. Cassavaugh J and Lounsbury KM: Hypoxia-mediated biological control. J Cell Biochem 112: 735-744, 2011.
23. Gort EH, Groot AJ, van der Wall E, van Diest PJ and Vooijs MA: Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 8: 60-67, 2008. (Pubitemid 351516825)
24. Rofstad EK: Microenvironment-induced cancer metastasis. Int J Radiat Biol 76: 589-605, 2000. (Pubitemid 30345160)
25. Ruan K, Song G and Ouyang G: Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107: 1053-1062, 2009.
26. Pez F, Dayan F, Durivault J, Kaniewski B, Aimond G, Le Provost GS, Deux B, Clezardin P, Sommer P, Pouyssegur J and Reynaud C: The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res 71: 1647-1657, 2011.
27. Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R and Giaccia AJ: Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22: 5907-5914, 2003. (Pubitemid 37176711)
28. Choi YK, Kim CK, Lee H, Jeoung D, Ha KS, Kwon YG, Kim KW and Kim YM: Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J Biol Chem 285: 32116-32125, 2010.